• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一批保存的球孢子菌素可诱导特异性球孢子菌迟发型超敏反应,并与球孢子菌细胞免疫反应的体外检测相关。

An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.

作者信息

Ampel Neil M, Hector Richard F, Lindan Christina P, Rutherford George W

机构信息

Department of Medicine , University of Arizona, Tucson, AZ, USA.

出版信息

Mycopathologia. 2006 Feb;161(2):67-72. doi: 10.1007/s11046-005-0218-8.

DOI:10.1007/s11046-005-0218-8
PMID:16463089
Abstract

No test for assessing cellular immune response in coccidioidomycosis is currently available in the United States. In the present study, we tested 49 healthy subjects living in the coccidioidal endemic region with a 1:55.8 dilution of a single lot of coccidioidin archived since the 1970s. In this group, 23 evaluable subjects demonstrated >/=5 mm of induration at 24, 48 or 72 h, with a mean+/-SEM maximum induration of 18.4+/-4.0 mm. The induration results among 14 subjects reactive at 24 h were compared to those from 179 individuals in an historical cohort studied in the 1980s using a reference lot of coccidioidin. Results were within 5% and not significantly different (P=0.924). The maximum induration response of all evaluable subjects correlated significantly with the results of in vitro tests of coccidioidal cellular immunity using supernatant interferon-gamma concentration and CD69 expression on T cells (Spearman rank correlation coefficients 0.69 and 0.68, respectively; P<0.01 for both). These data suggest that archived coccidioidin retains its potency and specificity and that in vitro test of coccidioidal immunity may have utility in the measurement of coccidioidal cellular immunity.

摘要

目前美国尚无用于评估球孢子菌病细胞免疫反应的检测方法。在本研究中,我们用自20世纪70年代起保存的一批球孢子菌素,以1:55.8的稀释度对49名生活在球孢子菌病流行地区的健康受试者进行了检测。在这组受试者中,23名可评估的受试者在24、48或72小时时硬结直径≥5毫米,平均最大硬结直径±标准误为18.4±4.0毫米。将14名在24小时时有反应的受试者的硬结结果与20世纪80年代使用一批参考球孢子菌素进行研究的179名历史队列受试者的结果进行比较。结果在5%以内,无显著差异(P = 0.924)。所有可评估受试者的最大硬结反应与使用上清液干扰素-γ浓度和T细胞上CD69表达进行的球孢子菌细胞免疫体外检测结果显著相关(Spearman等级相关系数分别为0.69和0.68;两者P均<0.01)。这些数据表明,保存的球孢子菌素保留了其效力和特异性,并且球孢子菌免疫的体外检测在测量球孢子菌细胞免疫方面可能有用。

相似文献

1
An archived lot of coccidioidin induces specific coccidioidal delayed-type hypersensitivity and correlates with in vitro assays of coccidioidal cellular immune response.一批保存的球孢子菌素可诱导特异性球孢子菌迟发型超敏反应,并与球孢子菌细胞免疫反应的体外检测相关。
Mycopathologia. 2006 Feb;161(2):67-72. doi: 10.1007/s11046-005-0218-8.
2
Measurement of cellular immunity in human coccidioidomycosis.人类球孢子菌病中细胞免疫的测量
Mycopathologia. 2003;156(4):247-62. doi: 10.1023/b:myco.0000003580.93839.71.
3
In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults.人类球孢子菌病细胞免疫的体外评估:健康成年人外周血单个核细胞的皮肤超敏反应、淋巴细胞转化和淋巴因子产生之间的关系
J Infect Dis. 1992 Apr;165(4):710-5. doi: 10.1093/infdis/165.4.710.
4
Measuring cellular immunity in coccidioidomycosis: the time is now.测量球孢子菌病中的细胞免疫:时机已到。
Mycopathologia. 2010 Jun;169(6):425-6. doi: 10.1007/s11046-010-9285-6. Epub 2010 Feb 16.
5
A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis.一种改良的球形孢子衍生的粗球荚膜菌(Spherusol),用于检测球孢子菌病的迟发型超敏反应。
Mycopathologia. 2012 Dec;174(5-6):353-8. doi: 10.1007/s11046-012-9555-6. Epub 2012 Jun 6.
6
The Return of Delayed-Type Hypersensitivity Skin Testing for Coccidioidomycosis.球孢子菌病迟发型超敏皮肤试验的重现。
Clin Infect Dis. 2015 Sep 1;61(5):787-91. doi: 10.1093/cid/civ388. Epub 2015 May 15.
7
Delayed-type hypersensitivity, in vitro T-cell responsiveness and risk of active coccidioidomycosis among HIV-infected patients living in the coccidioidal endemic area.生活在球孢子菌病流行地区的HIV感染患者的迟发型超敏反应、体外T细胞反应性及活动性球孢子菌病风险
Med Mycol. 1999 Aug;37(4):245-50.
8
Clinical comparison of two Mexican coccidioidins.两种墨西哥球孢子菌素的临床比较。
Mycopathologia. 2010 Jun;169(6):427-30. doi: 10.1007/s11046-010-9280-y. Epub 2010 Feb 23.
9
Revision and return of a coccidioidal skin test reagent.球孢子菌皮肤试验试剂的修订与返还
Mycopathologia. 2012 Dec;174(5-6):351-2. doi: 10.1007/s11046-012-9578-z.
10
In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.使用抗原制剂T27K对活动性球孢子菌病患者进行细胞免疫的体外全血分析。
Clin Diagn Lab Immunol. 2002 Sep;9(5):1039-43. doi: 10.1128/cdli.9.5.1039-1043.2002.

引用本文的文献

1
Review of Clinical and Laboratory Diagnostics for Coccidioidomycosis.《对球孢子菌病的临床和实验室诊断的评价》。
J Clin Microbiol. 2023 May 23;61(5):e0158122. doi: 10.1128/jcm.01581-22. Epub 2023 Mar 8.
2
Coccidioidomycosis: Changing Concepts and Knowledge Gaps.球孢子菌病:不断变化的概念与知识空白
J Fungi (Basel). 2020 Dec 10;6(4):354. doi: 10.3390/jof6040354.
3
Cytokine Release, Determined by a Multiplex Cytokine Assay, in Response to Coccidioidal Antigen Stimulation of Whole Blood among Subjects with Recently Diagnosed Primary Pulmonary Coccidioidomycosis.

本文引用的文献

1
Varieties of coccidioidal infection in relation to the epidemiology and control of the diseases.球孢子菌感染的种类与疾病的流行病学及控制的关系
Am J Public Health Nations Health. 1946 Dec;36(12):1394-1402. doi: 10.2105/ajph.36.12.1394.
2
The use of coccidioidin.球孢子菌素的应用。
Am Rev Tuberc. 1948 Apr;57(4):330-60. doi: 10.1164/art.1948.57.4.330.
3
Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.全血γ干扰素释放用于活动性球孢子菌病患者细胞免疫临床评估的初步评价
在最近诊断为原发性肺球孢子菌病的患者中,采用多元细胞因子分析检测全血对球孢子菌抗原刺激后的细胞因子释放情况。
mSphere. 2018 May 16;3(3). doi: 10.1128/mSphere.00065-18. eCollection 2018 May-Jun.
4
Cytokine Profiles from Antigen-Stimulated Whole-Blood Samples among Patients with Pulmonary or Nonmeningeal Disseminated Coccidioidomycosis.肺或非脑膜播散性球孢子菌病患者抗原刺激全血样本中的细胞因子谱
Clin Vaccine Immunol. 2015 Aug;22(8):917-22. doi: 10.1128/CVI.00280-15. Epub 2015 Jun 3.
5
Distance from construction site and risk for coccidioidomycosis, Arizona, USA.美国亚利桑那州建筑工地距离与球孢子菌病风险
Emerg Infect Dis. 2014 Sep;20(9):1464-71. doi: 10.3201/eid2009.131588.
6
Revision and return of a coccidioidal skin test reagent.球孢子菌皮肤试验试剂的修订与返还
Mycopathologia. 2012 Dec;174(5-6):351-2. doi: 10.1007/s11046-012-9578-z.
7
A reformulated spherule-derived coccidioidin (Spherusol) to detect delayed-type hypersensitivity in coccidioidomycosis.一种改良的球形孢子衍生的粗球荚膜菌(Spherusol),用于检测球孢子菌病的迟发型超敏反应。
Mycopathologia. 2012 Dec;174(5-6):353-8. doi: 10.1007/s11046-012-9555-6. Epub 2012 Jun 6.
8
The utility of fine needle aspiration for diagnosis of extrapulmonary coccidioidomycosis: a case report and discussion.细针穿刺抽吸术在肺外球孢子菌病诊断中的应用:一例报告及讨论
Clin Med Res. 2011 Nov;9(3-4):130-3. doi: 10.3121/cmr.2011.993. Epub 2011 May 11.
9
Clinical comparison of two Mexican coccidioidins.两种墨西哥球孢子菌素的临床比较。
Mycopathologia. 2010 Jun;169(6):427-30. doi: 10.1007/s11046-010-9280-y. Epub 2010 Feb 23.
10
Measuring cellular immunity in coccidioidomycosis: the time is now.测量球孢子菌病中的细胞免疫:时机已到。
Mycopathologia. 2010 Jun;169(6):425-6. doi: 10.1007/s11046-010-9285-6. Epub 2010 Feb 16.
Clin Diagn Lab Immunol. 2005 Jun;12(6):700-4. doi: 10.1128/CDLI.12.6.700-704.2005.
4
Patch testing with thimerosal in a Canadian center: an 11-year experience.
Am J Contact Dermat. 2003 Sep;14(3):138-43. doi: 10.2310/6620.2003.6152.
5
Measurement of cellular immunity in human coccidioidomycosis.人类球孢子菌病中细胞免疫的测量
Mycopathologia. 2003;156(4):247-62. doi: 10.1023/b:myco.0000003580.93839.71.
6
Prevalence of sensitivity to coccidioidin, with special reference to specific and nonspecific reactions to coccidioidin and to histoplasmin.球孢子菌素敏感性的患病率,特别提及对球孢子菌素和组织胞浆菌素的特异性及非特异性反应。
Dis Chest. 1957 Jan;31(1):35-60. doi: 10.1378/chest.31.1.35.
7
In vitro modulation of cytokine production by lymphocytes in human coccidioidomycosis.人球孢子菌病中淋巴细胞对细胞因子产生的体外调节
Cell Immunol. 2003 Feb;221(2):115-21. doi: 10.1016/s0008-8749(03)00067-4.
8
Increase in coccidioidomycosis--Arizona, 1998-2001.1998 - 2001年亚利桑那州球孢子菌病发病率上升
MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(6):109-12.
9
In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K.使用抗原制剂T27K对活动性球孢子菌病患者进行细胞免疫的体外全血分析。
Clin Diagn Lab Immunol. 2002 Sep;9(5):1039-43. doi: 10.1128/cdli.9.5.1039-1043.2002.
10
Assessment of the human cellular immune response to T27K, a coccidioidal antigen preparation, by flow cytometry of whole blood.通过全血流式细胞术评估人体对球孢子菌抗原制剂T27K的细胞免疫反应。
Med Mycol. 2001 Aug;39(4):315-20. doi: 10.1080/mmy.39.4.315.320.